CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
Capital Com Australia Pty Ltd Reguleret af ASIC Capital Com UK Limited Reguleret af Financial Conduct Authority (FCA) Capital Com SV Investments Limited Reguleret af CYSEC Сlosed Joint Stock Company «FinTech Solutions» Reguleret af NBRB Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Reguleret af FSA Capital Com Online Investments Ltd Reguleret af SCB Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Du kan også kontakte os: ring +44 2030978888 support@capital.com

Handel PLx Pharma Inc. - PLXP CFD

0.38
34.48%
  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.05
Long position, gebyr natten over

Long position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.024068%
Short position, gebyr natten over

Short position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
0.001846%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Nøglestatistikker
Tidligere luk* 0.58
Åben* 0.54
1-Års Ændring* 42.11%
Dagens Spænd* 0.38 - 0.54
52-Ugers Spænd 0.12-4.43
Gennemsnitlig Volumen (10 dage) 276.45K
Gennemsnitlig Volumen (3 måneder) 7.97M
Market Cap 4.43M
P/E-forhold -100.00K
Udestående aktier 29.14M
Omsætning 4.54M
EPS -0.99
Dividend (Udbytte %) N/A
Beta 3.85
Næste indtjeningsopgørelse Mar 28, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Nov 11, 2022 0.38 -0.16 -29.63% 0.54 0.54 0.38
Nov 10, 2022 0.58 -0.02 -3.33% 0.60 0.60 0.57
Nov 9, 2022 0.57 0.00 0.00% 0.57 0.59 0.57
Nov 8, 2022 0.58 -0.02 -3.33% 0.60 0.60 0.57
Nov 7, 2022 0.63 0.07 12.50% 0.56 0.63 0.56
Nov 4, 2022 0.60 -0.01 -1.64% 0.61 0.67 0.56
Nov 3, 2022 0.61 0.03 5.17% 0.58 0.62 0.58
Nov 2, 2022 0.58 0.00 0.00% 0.58 0.61 0.57
Nov 1, 2022 0.58 0.00 0.00% 0.58 0.59 0.57
Oct 31, 2022 0.59 0.00 0.00% 0.59 0.60 0.57
Oct 28, 2022 0.58 0.02 3.57% 0.56 0.60 0.56
Oct 27, 2022 0.56 0.00 0.00% 0.56 0.57 0.56
Oct 26, 2022 0.57 0.03 5.56% 0.54 0.57 0.54
Oct 25, 2022 0.53 -0.02 -3.64% 0.55 0.56 0.52
Oct 24, 2022 0.58 0.00 0.00% 0.58 0.60 0.58
Oct 21, 2022 0.58 0.00 0.00% 0.58 0.60 0.58
Oct 20, 2022 0.58 0.00 0.00% 0.58 0.60 0.58
Oct 19, 2022 0.58 0.01 1.75% 0.57 0.61 0.57
Oct 18, 2022 0.57 -0.02 -3.39% 0.59 0.59 0.55
Oct 17, 2022 0.56 0.03 5.66% 0.53 0.59 0.53

PLx Pharma Inc. Events

Tid (UTC) (UTC) Land Begivenhed
No events scheduled
Se alle begivenheder
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Total omsætning 8.208 0.03043 0.56546 0.75311 0.77866
Omsætning 8.208 0.03043 0.56546 0.75311 0.77866
Totale Driftsudgifter 48.998 13.4895 14.7678 11.7143 16.6265
Salgs/Generelle/Admin. Udgifter, Total 40.011 9.15057 10.0266 7.7916 10.175
Forskning & Udvikling 4.182 4.33897 4.74113 3.92267 4.15745
Usædvanlig Udgift (Indkomst) 0 2.29405
Driftsindtægter -40.79 -13.4591 -14.2023 -10.9612 -15.8478
Renteindkomst (Udgift), Netto Ikke-Drift -5.335 -1.75154 -6.3001 11.8576 -0.41889
Netto Indkomst Før Skat -46.125 -15.2107 -20.5024 0.89648 -16.2667
Netto Indkomst Efter Skat -46.125 -15.2107 -20.5024 0.89648 -15.3467
Netto Indkomst Før Ekstra Ting -46.125 -15.2107 -20.5024 0.89648 -15.3467
Netto Indkomst -46.125 -15.2107 -20.5024 0.89648 -15.3467
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -48.65 -16.948 -34.2532 0.89648 -15.3467
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -48.65 -16.948 -34.2532 0.89648 -15.3467
Fortyndet Netto Indkomst -48.65 -16.948 -34.2532 0.89648 -15.3467
Fortyndet Vægtet Gennemsnit Aktier 23.6505 9.71495 8.91619 8.73322 7.02048
Fortyndet EPS Uden Ekstraordinære Ting -2.05704 -1.74452 -3.84169 0.10265 -2.18599
Fortyndet Normaliseret EPS -2.05704 -1.74452 -3.84169 0.10265 -1.9736
Total Adjustments to Net Income -2.525 -1.7373 -13.7508
Kost af omsætning, Total 4.805
Bruttofortjeneste 3.403
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
Total omsætning 0.386 0.483 2.083 1.5919 6.6161
Omsætning 0.386 0.483 2.083 1.5919 6.6161
Totale Driftsudgifter 11.225 15.021 20.279 22.4437 16.4779
Salgs/Generelle/Admin. Udgifter, Total 9.142 13.645 18.456 20.8637 11.0132
Forskning & Udvikling 0.623 0.556 0.654 0.68778 1.55199
Driftsindtægter -10.839 -14.538 -18.196 -20.8518 -9.86185
Renteindkomst (Udgift), Netto Ikke-Drift 2.342 2.68 7.411 24.4142 -11.7807
Netto Indkomst Før Skat -8.497 -11.858 -10.785 3.56237 -21.6425
Netto Indkomst Efter Skat -8.497 -11.858 -10.785 3.56237 -21.6425
Netto Indkomst Før Ekstra Ting -8.497 -11.858 -10.785 3.56237 -21.6425
Netto Indkomst -8.497 -11.858 -10.785 3.56237 -21.6425
Total Adjustments to Net Income 0 0 0 -0.00004 0
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -8.497 -11.858 -10.785 3.56233 -21.6425
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -8.497 -11.858 -10.785 3.56233 -21.6425
Fortyndet Netto Indkomst -8.497 -11.858 -10.785 3.56233 -21.6425
Fortyndet Vægtet Gennemsnit Aktier 28.6034 27.6935 27.5392 27.5742 26.9119
Fortyndet EPS Uden Ekstraordinære Ting -0.29706 -0.42819 -0.39162 0.12919 -0.8042
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS -0.29706 -0.42819 -0.39162 0.12919 -0.8042
Kost af omsætning, Total 1.46 0.82 1.169 0.89226 3.91274
Bruttofortjeneste -1.074 -0.337 0.914 0.69964 2.70336
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Totale Nuværende Aktiver 73.476 22.9855 14.2833 14.8654 25.69
Likvider og Kortsigtede Investeringer 69.392 22.4487 14.0013 14.2503 24.4044
Likvider & Lignende 69.392 22.4487 14.0013 14.2503 24.4044
Totale Tilgodehavender, Netto 0.634 0 0.01868 0.01823 0.01938
Accounts Receivable - Trade, Net 0.634 0 0.01868 0.01823 0.01938
Total Inventory 2.458 0.14338 0 0.24637
Prepaid Expenses 0.992 0.39347 0.26327 0.40937 0.30017
Other Current Assets, Total 0 0.18754 0.71967
Total Assets 76.642 26.6166 18.5028 18.3884 28.8486
Property/Plant/Equipment, Total - Net 1.088 1.55304 2.0848 1.39423 1.02988
Goodwill, Net 2.061 2.06102 2.06102 2.06102 2.06102
Intangibles, Net
Other Long Term Assets, Total 0.017 0.01704 0.07367 0.06771 0.06771
Total Current Liabilities 11.879 3.54231 6.09343 4.73266 1.81569
Payable/Accrued 10.6 0.86257 0.92892 0.65305 0.85216
Accrued Expenses 1.278 2.02327 1.50639 1.1699 0.96354
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 24.962 16.1636 16.9331 11.9441 24.2322
Total Long Term Debt 0 0 0.62227 4.28039 6.94215
Other Liabilities, Total 13.083 12.6213 10.2174 2.93104 15.4743
Total Equity 51.68 10.453 1.56962 6.44429 4.61639
Common Stock 0.028 0.01391 0.00916 0.00874 0.00872
Additional Paid-In Capital 183.912 91.203 74.8371 72.8713 71.9399
Retained Earnings (Accumulated Deficit) -148.274 -102.149 -86.9382 -66.4358 -67.3323
Total Liabilities & Shareholders’ Equity 76.642 26.6166 18.5028 18.3884 28.8486
Total Common Shares Outstanding 27.5392 13.9116 9.15626 8.74395 8.72282
Property/Plant/Equipment, Total - Gross 1.553 2.00154 2.52769 1.68631 1.479
Accumulated Depreciation, Total -0.465 -0.4485 -0.44288 -0.29208 -0.44912
Long Term Debt 0 0.62227 4.28039 6.94215
Current Port. of LT Debt/Capital Leases 0 0.62227 3.65812 2.90971
Preferred Stock - Non Redeemable, Net 16.014 21.3849 13.6616
Other Current Liabilities, Total 0.001 0.03421
Total Preferred Shares Outstanding 0.01501 0.023
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Totale Nuværende Aktiver 57.748 73.476 88.6142 82.013 84.8674
Likvider og Kortsigtede Investeringer 52.499 69.392 82.5543 80.1695 84.4235
Likvider & Lignende 52.499 69.392 82.5543 80.1695 84.4235
Total Inventory 3.839 2.458 2.19035 1.26248 0.14338
Prepaid Expenses 0.712 0.992 0.61625 0.58101 0.30056
Total Assets 60.858 76.642 91.8361 85.3085 88.3209
Property/Plant/Equipment, Total - Net 1.032 1.088 1.14378 1.21751 1.37546
Goodwill, Net 2.061 2.061 2.06102 2.06102 2.06102
Other Long Term Assets, Total 0.017 0.017 0.01704 0.01704 0.01704
Total Current Liabilities 13.23 11.879 7.40538 3.06477 1.40919
Payable/Accrued 12.716 10.6 6.45217 2.38232 0.96261
Accrued Expenses 0.51113 1.278 0.95321 0.64824 0.41238
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0 0
Other Current Liabilities, Total 0.00287 0.001 0.03421 0.03421
Total Liabilities 18.875 24.962 44.9288 29.1794 22.2751
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 5.645 13.083 37.5234 26.1146 20.8659
Total Equity 41.983 51.68 46.9073 56.1292 66.0459
Preferred Stock - Non Redeemable, Net 16.014 16.014 16.0136 16.0136 21.3849
Common Stock 0.028 0.028 0.02748 0.02615 0.02284
Additional Paid-In Capital 185 183.912 182.702 170.283 158.327
Retained Earnings (Accumulated Deficit) -159.059 -148.274 -151.836 -130.194 -113.689
Total Liabilities & Shareholders’ Equity 60.858 76.642 91.8361 85.3085 88.3209
Total Common Shares Outstanding 27.5392 27.5392 27.477 26.145 22.8363
Total Preferred Shares Outstanding 0.01501 0.01501 0.01501 0.01501 0.023
Totale Tilgodehavender, Netto 0.698 0.634 3.25331
Accounts Receivable - Trade, Net 0.698 0.634 3.25331
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Netto indkomst/Startlinje -46.125 -15.2107 -20.5024 0.89648 -15.3467
Likvider Fra Driftsaktiviteter -32.118 -12.2436 -12.659 -9.49923 -13.3066
Likvider Fra Driftsaktiviteter 0.116 0.12462 0.15825 0.20096 0.02984
Deferred Taxes 0 -0.92
Ikke-Likvide Ting 8.38 3.04205 6.8139 -10.8456 4.91663
Cash Taxes Paid 0 0 0 0 0
Likvid Rente Betalt 0.006 0.21286 0.6003 0.67115 0.19594
Ændringer i Driftskapital 5.511 -0.19961 0.8712 0.24895 -1.9863
Likvider fra Investeringsaktiviteter 0.095 -0.102 -0.23029 -0.65487 11.2389
Kapitaludgifter 0 -0.102 -0.24174 -0.65487 -0.53757
Andre Investerings-Cash-Flow-Ting, Total 0.095 0.01144 0 11.7764
Likvider fra Financieringsaktiviteter 78.966 20.7929 12.6404 0 26.4127
Udstedelse (Pensionering) af Aktier, Netto 79.591 24.5429 15.7654 0 23.8444
Udstedelse (Pensionering) af Gæld, Netto -0.625 -3.75 -3.125 0 2.5683
Netto Ændring i Likviditet 46.943 8.44735 -0.24896 -10.1541 24.345
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -10.785 -46.125 -49.6874 -28.0449 -11.5405
Cash From Operating Activities -16.893 -32.118 -18.7567 -9.75913 -4.28206
Cash From Operating Activities 0.03 0.116 0.08574 0.05554 0.02656
Non-Cash Items -6.32 8.38 31.7794 19.2826 8.61713
Cash Taxes Paid 0 0 0 0 0
Cash Interest Paid 0 0.006 0.00649 0.00649 0.60195
Changes in Working Capital 0.182 5.511 -0.93438 -1.05234 -1.38523
Cash From Investing Activities 0.095 0.09454 0.04524 0
Capital Expenditures 0 0 0
Cash From Financing Activities 0 78.966 78.7678 67.4347 66.2569
Issuance (Retirement) of Stock, Net 0 79.591 79.3928 68.0597 66.8819
Issuance (Retirement) of Debt, Net 0 -0.625 -0.625 -0.625 -0.625
Net Change in Cash -16.893 46.943 60.1057 57.7208 61.9748
Other Investing Cash Flow Items, Total 0.095 0.09454 0.04524
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
Level One Partners LLC Corporation 9.5157 2772643 1452337 2021-12-31
White Rock Capital Management, L.P. Hedge Fund 7.4574 2172900 852594 2021-12-31
Park West Asset Management LLC Hedge Fund 5.0561 1473218 0 2022-12-31 MED
Hardie Robert D Individual Investor 4.0223 1172000 297000 2021-12-31
Green Square Capital Advisors, LLC Investment Advisor 3.3874 987000 794000 2022-12-31 LOW
Valentino (Michael J) Individual Investor 1.6978 494690 0 2022-09-19 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4013 408320 733 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1618 338522 -777284 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8151 237491 -13361 2022-12-31 LOW
Ground Swell Capital, LLC Investment Advisor 0.751 218820 176311 2022-12-31 HIGH
Jane Street Capital, L.L.C. Research Firm 0.6607 192504 192504 2022-12-31 HIGH
Morgan Stanley Smith Barney LLC Investment Advisor 0.6513 189785 -44319 2022-12-31 LOW
University of Texas Investment Management Company Endowment Fund 0.4302 125346 0 2022-12-31 LOW
HRT Financial LP Investment Advisor 0.2984 86942 86942 2022-12-31 HIGH
UBS Financial Services, Inc. Investment Advisor 0.2873 83723 27752 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 0.2835 82604 -179302 2022-12-31 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2716 79132 0 2022-12-31 LOW
Virtu Americas LLC Research Firm 0.2449 71368 71368 2022-12-31 HIGH
Ergoteles Capital Hedge Fund 0.2086 60771 60771 2022-12-31 HIGH
Renaissance Technologies LLC Hedge Fund 0.187 54500 54500 2022-12-31 HIGH

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

500K+

Handlende

92K+

Månedlkige, aktive klienter

$53M+

Månedlig investeringsvolumen

$30M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long
Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
Fortjeneste/Tab

PLx Pharma Inc. Company profile

Om PLx Pharma Inc.

PLx Pharma Inc. er en lægemiddelvirksomhed. Selskabet er fokuseret på sin PLxGuard-platform til lægemiddeloverførsel. Dens kerneprodukt omfatter VAZALORE, der fås i to doser 325 milligram (mg) og 81 mg, er en formulering af aspirin, som klinisk har vist sig at give trombocythæmning til patienter med vaskulære sygdomme og diabetespatienter, der kan være kandidater til aspirinbehandling. PLxGuard-leveringssystemet anvender overfladevirkende lipider, såsom phospholipider og frie fedtsyrer, til at ændre de fysiokemiske egenskaber af forskellige lægemidler med en målrettet frigivelse til udvalgte dele af mave-tarmkanalen. Virksomhedens produktpipeline omfatter også andre orale ikke-steroide antiinflammatoriske lægemidler (NSAID), der anvender PLxGuard-platformen til lægemiddelafgivelse, herunder PL1200 Ibuprofen 200 mg og PL1200 Ibuprofen 400 mg, til smerte- og inflammationsbehandling i klinisk fase I.

Industry: Pharmaceuticals (NEC)

9 Fishers Ln Ste E
07871-2402

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

US100

12,564.00 Price
-1.150% 1D Chg, %
Long position, gebyr natten over -0.0241%
Short position, gebyr natten over 0.0018%
Gebyr natten over, tid 21:00 (UTC)
Spænd 1.8

Oil - Crude

73.40 Price
+0.340% 1D Chg, %
Long position, gebyr natten over -0.0153%
Short position, gebyr natten over -0.0066%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.03

Gold

1,972.66 Price
+0.770% 1D Chg, %
Long position, gebyr natten over -0.0180%
Short position, gebyr natten over 0.0097%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

XRP/USD

0.52 Price
+6.930% 1D Chg, %
Long position, gebyr natten over -0.0753%
Short position, gebyr natten over 0.0069%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.00523

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel